Viemed Healthcare (VMD) Cost of Revenue (2018 - 2026)

Viemed Healthcare has reported Cost of Revenue for 9 years, with the latest figure at $32.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 26.06% year-over-year to $32.6 million; the trailing twelve-month figure through Mar 2026 stood at $121.6 million (up 26.48% YoY), and the FY2025 full-year result was $114.8 million, up 26.1% from the prior year.
• Cost of Revenue for Q1 2026 stood at $32.6 million, up from $32.1 million in the prior quarter.
• The five-year high for Cost of Revenue was $32.6 million in Q1 2026, with the low at $12.5 million in Q1 2022.
• Historically, Cost of Revenue has averaged $21.3 million across 5 years, with a median of $20.8 million in 2024.
• Annual changes were most pronounced in 2022 — Cost of Revenue climbed 17.22% — and 2024, when it soared 33.69%.
• Viemed Healthcare's Cost of Revenue stood at $14.6 million in 2022, then advanced by 27.48% to $18.6 million in 2023, then jumped by 31.83% to $24.6 million in 2024, then surged by 30.63% to $32.1 million in 2025, then advanced by 1.59% to $32.6 million in 2026.
• The last three Cost of Revenue figures came in at $32.6 million (Q1 2026), $32.1 million (Q4 2025), and $30.6 million (Q3 2025), per Business Quant data.